Artá Capital has reached an agreement with the Mena Gericó family to acquire a stake in Magapor, S.L., a global leader in the design, development, manufacturing and commercialization of technology and products for swine artificial insemination. The transaction marks Artá Capital’s entry as the Group’s reference shareholder, with the aim of supporting its next phase of international growth.
Founded and headquartered in Ejea de los Caballeros (Zaragoza, Spain), Magapor is a leading company in the animal reproductive biotechnology sector, with more than 35 years of experience. The Group offers a comprehensive range of solutions—including semen extenders, catheters, insemination bags and specialized equipment—which are distributed in more than 60 countries through a well-established international commercial network. In 2025, the Group generated consolidated revenues of approximately €24 million, with international sales accounting for 73% of total revenue.
The company will continue to be led by Jesús Mena Gericó and Juan José Mena Gericó, who will retain a significant ownership stake in the business. Artá Capital intends to continue supporting the management team in accelerating the Group’s international expansion, strengthening its R&D&I capabilities, and consolidating its global leadership in the swine reproduction sector.
Artá Capital was advised by Garrigues as legal counsel, Auren as financial advisor, Deloitte for the financial, tax, legal and labor due diligence, PwC for the commercial due diligence, and Kenta as debt advisor.
This transaction represents the fifth investment made by Artá Capital Fund III, which closed in November 2024 with total commitments of €400 million.
About Magapor
Headquartered in Ejea de los Caballeros (Zaragoza, Spain), Magapor is a group specializing in the design, manufacturing and distribution of technology for swine artificial insemination. With more than three decades of experience, the Group offers a comprehensive portfolio of products and solutions—including semen extenders, catheters, insemination bags, laboratory equipment and services—distributed in more than 60 countries.
Magapor is recognized for the quality of its products, its strong commitment to R&D&I—having received Spain’s National Innovation Award in 2023 in the Innovative SME category and the European Technology and Innovation Award from AEITI in 2021—and its ability to deliver tailored solutions to artificial insemination centers and pig farms worldwide.
The company is vertically integrated and operates manufacturing facilities in Spain, China and Brazil, as well as a commercial office in the United States.
More information: www.magapor.com.
About Artá Capital
Artá Capital is a growth capital investment manager focused on the Iberian market. Since its establishment in 2008, it has been one of the most active investment firms in the region, investing more than €1 billion in 25 leading companies across a variety of sectors and completing more than 65 add-on acquisitions through its portfolio companies.
More information:https://www.artacapital.com/.
cloud technology axon
Encomenda, through its Encomenda Seed II fund, has led a €300,000 fu...
